Bora Pharmaceuticals Injectables Inc.

Form 483 issued August 1, 2012 · Baltimore, Maryland

Inspection
Jul 23 – Aug 1, 2012
Observations
1
Pages
2
FEI number
1000512361

In short: On August 1, 2012, FDA issued a Form 483 with 1 observation to Bora Pharmaceuticals Injectables Inc. in Baltimore, Maryland (FEI 1000512361) after an inspection that ran Jul 23 – Aug 1, 2012. The investigator was Rachel C. Harrington. Most observations concern production; the most-cited regulation is 21 CFR 211.100 (written procedures; deviations).

At a glance

1 of 1 observations on this 483 concern production.

Production1

Most cited: 21 CFR 211.100(b) (1×)

What FDA observed

Preview: the opening words of each observation
  1. 01

    Deviations from written production and process control…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Bora Pharmaceuticals Injectables Inc.?

FDA listed 1 observation on this Form 483, mostly about production. The most-cited regulation is 21 CFR 211.100 (written procedures; deviations). The opening words of each observation are shown on this page.

Who inspected Bora Pharmaceuticals Injectables Inc.?

Rachel C. Harrington is named on this Form 483, for the inspection of Jul 23 – Aug 1, 2012. Each investigator has a profile showing what they cite most.

When was Bora Pharmaceuticals Injectables Inc. inspected by FDA?

The inspection ran Jul 23 – Aug 1, 2012, and the Form 483 is dated August 1, 2012.

How do I get the full Form 483 for Bora Pharmaceuticals Injectables Inc.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free